0001714899-24-000088.txt : 20240301
0001714899-24-000088.hdr.sgml : 20240301
20240301165117
ACCESSION NUMBER: 0001714899-24-000088
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20240301
DATE AS OF CHANGE: 20240301
EFFECTIVENESS DATE: 20240301
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Denali Therapeutics Inc.
CENTRAL INDEX KEY: 0001714899
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 463872213
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-506551
FILM NUMBER: 24710869
BUSINESS ADDRESS:
STREET 1: 161 OYSTER POINT BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 866-8548
MAIL ADDRESS:
STREET 1: 161 OYSTER POINT BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
D
1
primary_doc.xml
X0708
D
LIVE
0001714899
Denali Therapeutics Inc.
161 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO
CA
CALIFORNIA
94080
(650) 866-8548
DELAWARE
None
None
Corporation
true
Ryan
Watts
c/o Denali Therapeutics Inc.
161 Oyster Point Blvd.
South San Francisco
CA
CALIFORNIA
94080
Executive Officer
Director
Alexander
O.
Schuth
c/o Denali Therapeutics Inc.
161 Oyster Point Blvd.
South San Francisco
CA
CALIFORNIA
94080
Executive Officer
Carole
Ho
c/o Denali Therapeutics Inc.
161 Oyster Point Blvd.
South San Francisco
CA
CALIFORNIA
94080
Executive Officer
Jennifer
Cook
c/o Denali Therapeutics Inc.
161 Oyster Point Blvd.
South San Francisco
CA
CALIFORNIA
94080
Director
Jay
T.
Flatley
c/o Denali Therapeutics Inc.
161 Oyster Point Blvd.
South San Francisco
CA
CALIFORNIA
94080
Director
Erik
Harris
c/o Denali Therapeutics Inc.
161 Oyster Point Blvd.
South San Francisco
CA
CALIFORNIA
94080
Director
Peter
S.
Klein
c/o Denali Therapeutics Inc.
161 Oyster Point Blvd.
South San Francisco
CA
CALIFORNIA
94080
Director
Steve
E.
Krognes
c/o Denali Therapeutics Inc.
161 Oyster Point Blvd.
South San Francisco
CA
CALIFORNIA
94080
Director
Vicki
L.
Sato
c/o Denali Therapeutics Inc.
161 Oyster Point Blvd.
South San Francisco
CA
CALIFORNIA
94080
Director
David
P.
Schenkein
c/o Denali Therapeutics Inc.
161 Oyster Point Blvd.
South San Francisco
CA
CALIFORNIA
94080
Director
Marc
Tessier-Lavigne
c/o Denali Therapeutics Inc.
161 Oyster Point Blvd.
South San Francisco
CA
CALIFORNIA
94080
Director
Nancy
A.
Thornberry
c/o Denali Therapeutics Inc.
161 Oyster Point Blvd.
South San Francisco
CA
CALIFORNIA
94080
Director
Biotechnology
Decline to Disclose
- 06b
false
2024-02-29
false
true
true
false
0
499732711
499732711
0
false
11
0
0
0
false
Denali Therapeutics Inc.
/s/ Ryan Watts
Ryan Watts
President and CEO
2024-02-29